The Bayer Group to sell metal business for €1.2bn

The Bayer Group will sell H.C. Starck to equal investors Advent International and The Carlyle Group for €1.2 billion, helping to finance the acquisition of pharmaceutical company Schering.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this